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Abstract
Background A correlation between renal mass and nephron
number in newborns allows the use of total kidney volume
at birth as a surrogate for congenital nephron number. As the
bone morphogenetic protein type 4 (BMP4), and its receptor
type 1A (BMPR1A, ALK3), play an important role in renal
development, we hypothesized that common, functional
polymorphisms in their genes might be responsible for
variation in kidney size among healthy individuals.
Methods We recruited 179 healthy full-term newborns born
to healthy women. Kidney volume was measured sono-
graphically. Total kidney volume (TKV) was calculated as
the sum of left and right kidneys, and normalized for body
surface area (TKV/BSA). Genomic DNA was extracted
from umbilical cord blood leukocytes, and c.455T > C
(rs17563) BMP4 and c.67+5659A > T (rs7922846)
BMPR1A genotypes were identified by PCR-RFLP.
Results TKV/BSA in newborns carrying at least one A
BMPR1A allele (AA + AT) was significantly reduced by
approximately 13 % as compared with TT homozygous
newborns (106.7±21.5 ml/m2 vs. 122.7±43.8 ml/m2, p<
0.02). No significant differences in TKV/BSA were found
among newborns with different BMP4 genotypes.
Conclusions Results suggest that rs7922846 BMPR1A poly-
morphism may account for subtle variation in kidney size at
birth, reflecting congenital nephron endowment.
Keywords Bone morphogenetic proteins . Gene
polymorphism . Nephron number . Newborns . Branching
morphogenesis
Introduction
Suboptimal nephron number may be associated with in-
creased risk for essential hypertension and susceptibility to
renal injury [1–4], but the factors that set nephron number
during kidney development remain largely undefined [5].
Nonetheless, genetic studies in humans and mice have pro-
vided valuable insights into the possible genetic contribu-
tion and molecular mechanisms leading to normal nephron
endowment and renal hypoplasia [2]. In humans, final neph-
ron endowment for life is determined during late gestation
and displays wide individual variation (210,332 to
2,702,079 nephrons per kidney) [6–8]. El Kares et al. hy-
pothesized that congenital nephron number is a multifacto-
rial trait controlled by the interaction of environmental
factors and genetic variants that influence the extent of
branching nephrogenesis during fetal life [9]. In addition,
confirmation of a strong correlation between renal mass and
nephron number in newborns allows the use of the total
kidney volume at birth (measured by ultrasonography) as a
surrogate for congenital nephron number [10].
Bone morphogenetic proteins (BMPs) belong to the
Transforming Growth Factor-β (TGF-β) family, with more
than 30 members that bind to two types of serine-threonine
kinase receptors, i.e., type 1 (BMPR1) and type 2 (BMPR2)
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receptors [11]. Although BMPs were first identified as fac-
tors that induce the formation of bone and cartilage when
implanted at ectopic sites in rats [11], they are now
known to be implicated in a variety of developmental
processes [12]. The spatial and temporal expression of
Bone Morphogenetic Protein type 2 or type 4 (BMP2 or
BMP4, respectively) and their shared receptor, BMP re-
ceptor type 1A (BMPR1A)—also known as Activin-Like
Kinase 3 (ALK3) [11]—suggests a functional role for
BMP signaling during the formation of intermediate
mesoderm-derived organs, including the mammalian kid-
ney [13]. In 2008, Weber et al. identified BMP4 muta-
tions causing renal hypodysplasia, characterized by a
reduction in nephron number and a small overall kidney
size [14]. Recently, Di Giovanni et al. reported that Alk3-
deficient mice exhibit simple renal hypoplasia character-
ized by decreases in both kidney size and nephron num-
ber, but with normal tissue architecture [13]. In 2009,
Capasso et al. [15] found that cutaneous melanoma-
associated c.455T > C (rs17563) BMP4 polymorphism,
resulting in an amino acid change from valine to alanine
at residue 152 (p.Val152Ala), affects BMP4 gene expres-
sion, and Boettcher et al. suggested that the obesity-
associated c.67+5659A > T (rs7922846) BMPR1A poly-
morphism modulates BMPR1A mRNA levels [16].
Thus far, several common polymorphisms in developmen-
tal genes including PAX2 [5], RET [10], ALDH1A2 [9], OSR1
[17], and ACE [18] have been associated with subtle variation
in kidney size at birth. These findings lend support to the
hypothesis that common, functional polymorphisms in
BMP4 and/or BMPR1A may be responsible for the variation
in nephron number that is seen amongst healthy individuals.
To verify this hypothesis, we examined the association of
nonsynonymous rs17563 BMP4 and intronic rs7922846
BMPR1A polymorphisms with congenital kidney volume, a
surrogate measure of the number of nephrons, in a cohort of
healthy, full-term newborns in Poland.
Methods
Study subjects
At the Department of Neonatal Diseases at the Pomeranian
Medical University in Szczecin, we prospectively recruited
179 consecutive healthy Polish newborns (79 females and 100
males), born after the end of the 37th week of gestation to
healthy women with uncomplicated pregnancies. All children
were breast-fed and free of medication. Twins, infants of
mothers with preeclampsia, hypertension of any cause, diabe-
tes, history of illicit substance use, or antenatal steroid therapy
were excluded. Other exclusion criteria were congenital infec-
tion, intra-uterine growth restriction (i.e., below the 10th
percentile birth mass, length, or head circumference), chro-
mosomal aberrations or congenital malformations. At birth,
cord blood of newborns was obtained for isolation of genomic
DNA. The gender of the newborn, birth mass (BM), and birth
length (BL) were taken from standard hospital records. Body
surface area (BSA) was calculated as the square root of [BL
(cm) × BM (kg)/3600] according to Mosteller [19]. The study
was approved by the local ethics committee and parents gave
informed consent.
Kidney volume measurement
Sonographic examination was performed in newborns on the
third day after delivery with an EnVisor C machine (Philips
Canada, Markham, Ontario, Canada) using a 5-MHz sector
probe (Philips Canada) and 10-MHz linear probe (Philips
Canada) as described previously [20, 21]. Left and right
kidney volumes (LKVand RKV, respectively) were calculated
using the following formula for volume of an ellipsoid:
kidney volume ¼ 4 3=ð Þ  Pi½ ðlength 2= Þ  height 2=ð Þ 
width 2=ð Þ [5]. Total kidney volume (TKV) was calculated as
the sum of LKV and RKV. Subsequently, TKV was normal-
ized for body surface area (TKV/BSA) [5, 20].
Determination of BMP4 and BMPR1A genotypes
Genomic DNA from cord blood was isolatedwith the QIAamp
Blood DNA Mini Kit (QIAGEN, Germany). For the analysis
of the rs17563 BMP4 gene polymorphism, a polymerase chain
reaction/restriction fragment length polymorphism (PCR/
RFLP) method was designed with the following primer pair:
forward: 5′-ACTCTgCTTTTCgTTTCCTCTTTA-3′ and
reverse 5′-ggCCCAATTCCCACTCC-3′ primers (TIB MOL
BIOL, Poznań, Poland). The BMP4 amplicons were subse-
quently digested with HphI enzyme (MBI Fermentas, Vilnius,
Lithuania). The PCR BMP4 product of 395 base pairs (bp) was
cut into fragments of 244, 75, 62, and 14 bp from the T allele
and 306, 75, and 14 bp from the C allele.
DNA fragments that contained the rs7922846 BMPR1A
polymorphism were amplified by PCR with forward 5′-
TTTCAgCGCTCAATAgACAC-3 ′ and reverse 5 ′-
TCCCTCCCCCTTTCATA-3′ primers. PCR-RFLP with
the AccI restriction enzyme was performed. In the case of
the T allele, the final product of 541 bp remained undigest-
ed, while the A variant gave restriction fragments of 352 bp
and 189 bp. The restriction fragments in each case were
electrophoretically separated and visualized in ethidium
bromide-stained 3 % agarose gels.
Statistical analysis
Possible divergence of BMP4 or BMPR1A genotype fre-
quencies from Hardy-Weinberg equilibrium was assessed
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using a χ2 test. The distribution of each quantitative variable
was tested for skewedness. Quantitative data were presented
as means ± SD. Association of either gender or genotype
(with respect to dominant and recessive modes of inheri-
tance of the minor alleles) with each outcome variable was
assessed by Student’s t test using STATISTICA (StatSoft,
Inc. (2011), version 10). Statistical significance was defined
as p<0.05.
Results
All PCR samples were genotyped twice and a concordance
rate of 100 % was attained. There were 57 CC BMP4
homozygotes (31.8 %), 93 CT heterozygotes (52.0 %), and
29 TT homozygotes (16.2 %). There were 82 AA BMPR1A
homozygotes (45.8 %), 81 AT heterozygotes (45.3 %), and
16 TT homozygotes (8.9 %). The frequencies of the minor
alleles were: 42.2 % (39.5 % in newborn males and 45.6 %
in newborn females) and 31.6 % (33.0 % in newborn males
and 29.7 % in newborn females) for T BMP4 and T
BMPR1A, respectively.
Both BMP4 and BMPR1A genotype distributions con-
formed to the expected Hardy-Weinberg equilibrium (p0
0.545 and p00.607, respectively). Characteristics of the
newborn cohort (n0179) with respect to gender are shown
in Table 1.
The distribution of these characteristics in our cohort, in-
cluding kidney size, approached normality (skewedness<2
for all variables). The mean values of birth mass and BSA in
male newborns were significantly higher as compared with
female newborns. No significant differences in gestational
age, birth length, LKV, RKV, LKV/RKV, TKV, and TKV/
BSAwere found between male and female newborns.
Characteristics of kidney volumes with respect to
rs17563 BMP4 and rs7922846 BMPR1A polymorphisms
are shown in Table 2. Mean values of TKV and TKV/BSA
in newborns with at least one A allele (AA + AT) were
significantly lower as compared with TT BMPR1A homo-
zygotes (24.7±5.5 ml versus 28.0±10.0 ml and 106.7±
21.5 ml/m2 versus 122.7±43.8 ml/m2, respectively). No
significant differences in LKV, RKV, LKV/RKV ratio were
found among newborns with different BMPR1A genotypes.
No significant differences in LKV, RKV, LKV/RKV ratio,
TKV, and TKV/BSA were found among newborns with
different BMP4 genotypes.
Discussion
The present study demonstrates for the first time an associ-
ation of rs7922846 (c.67+5659A > T) BMPR1A polymor-
phism, but not rs17563 (c.455 T > C) BMP4, with kidney
size in Polish full-term newborns. Total kidney volume,
standardized for body surface area (TKV/BSA), in
newborns carrying at least one A BMPR1A allele (AA +
AT) was reduced by approximately 13 % as compared with
TT homozygous newborns (a recessive genetic model for
the T allele). The number of nephrons formed during fetal
organogenesis seems to be an important determinant of
human health, and reduced nephron endowment may result
in pathological states ranging from early renal failure to
adult-onset hypertension, depending on the severity of
nephron deficiency [1–4].
We found no relationship between rs7922846 and kidney
volume under the assumption of dominant genetic model for
the T allele (TT + AT versus AA). Therefore, our results
support a dominance of the A BMPR1A allele, which is
evidenced in the similarity of kidney volumes, TKV/BSA
in particular, in carriers of at least one A allele. Recently,
Böttcher et al. [16] reported a significant association between
rs7922846 variant and mRNA expression of BMPR1A only in
the dominant model for the Tallele (TT + AT versus AA). The
recessive model, however, was not calculated due to the small
sample size of the groups of subjects homozygous for the T
allele [16]. Further research may be needed to determine
which genetic model best matches the actual underlying mode
of inheritance of the A allele, associated with reduced total
kidney volume.
Although the TKV/BSA was significantly associated
with BMPR1A variant, the effect of this polymorphism was
less evident when individual kidneys were evaluated. We
previously showed that the common angiotensin converting
enzyme (ACE) insertion/deletion (I/D) polymorphism was
not only associated with the TKV/BSA but also with indi-
vidual kidney volumes [18]. While the ACE DD homozy-
gotes accounted for around 25 % of all genotypes in the










39.5±1.3 39.5±1.2 39.4±1.4 0.711
BM (kg) 3.47±0.45 3.55±0.48 3.37±0.37 0.007
BL (m) 0.56±0.03 0.56±0.03 0.56±0.03 0.334
BSA (m2) 0.232±0.019 0.235±0.021 0.228±0.016 0.018
LKV (ml) 12.9±3.4 13.3±3.5 12.5±3.1 0.121
RKV (ml) 12.1±3.3 12.5±3.5 11.7±3.0 0.102
LKV/RKV 1.09±0.24 1.09±0.28 1.09±0.20 0.853
TKV (ml) 25.0±6.1 25.7±6.3 24.1±5.6 0.079
TKV/BSA
(ml/m2)
108.2±24.6 109.7±25.1 106.2±24.0 0.338
BM body mass, BL birth length, BSA body surface area, LKV left
kidney volume, RKV right kidney volume, TKV total kidney volume
aMales vs. females
Pediatr Nephrol (2013) 28:433–438 435
aforementioned study [18], the frequency of BMPR1A TT
homozygotes in the present study was 8.9 %. Therefore, the
low statistical power due to insufficient sample size may
have led to borderline significance for individual, left and
right kidneys.
The intermediate mesoderm, differentiating into the meta-
nephric blastema (and then metanephric mesenchyme) and
ureteric bud [22], gives rise to the permanent kidney, but
extrinsic signals altering gene expression are required to com-
mit the intermediate mesoderm to a renal lineage [13]. James
and Schultheiss showed that BMP-ALK signaling modulates
gene expression patterns in the intermediate mesoderm in
vitro and in vivo [23]. BMPR1A (ALK3) is one of the three
type 1 BMP (bone morphogenetic protein) receptors that are
essential for BMP signaling [24]. Böttcher et al. [16] showed
that non-diabetic homozygous carriers of the obesity risk
alleles for rs7922846 (c.67+5659A) and three other BMPR1A
variants (rs7095025, rs11202222, and rs10788528) had
higher visceral and subcutaneous adipose tissue mRNA ex-
pression of BMPR1A, yet only rs7922846 was significantly
associated with increased visceral mRNA expression [16].
Moreover, this polymorphism is in strong linkage disequilib-
rium with another nonsynonymous rs11528010 BMPR1A
polymorphism causing the amino acid substitution of proline
by threonine at residue 2 (p.Pro2Thr) located in the potential
BMPR1A signal peptide chain that could affect posttransla-
tional transport of BMPR1A [16].
In our study, carriers of the A allele of BMPR1A polymor-
phism, associated with increased ALK3 mRNA expression,
had significantly smaller kidney size as compared with TT
homozygous newborns. Animal studies show that both de-
creased and increased expression of active ALK3 receptor
may ultimately result in deficient UB branching [25, 26].
Although both ALK3 loss-of-function and gain-of-function
mutation mouse models exhibit similar outcomes, the mech-
anisms underlying these outcomes are distinct [26]. While
ALK3 deficiency disrupts UB patterning—an increased num-
ber of first and second UB branches followed by a decrease in
the number of subsequent branches formed—resulting in an
overall reduction in UB number, the constitutive overexpres-
sion of ALK3 inhibits branchingmorphogenesis [26]. As even
minor defects of UB branching can result in a marked de-
crease in nephron number [27], we thus hypothesize that the
reduced kidney size seen in healthy newborns carrying at least
one A BMPR1A allele might be due to subtle decreases in the
efficiency of UB branching, possibly mediated by increased
expression of BMPR1A mRNA [16]. However, whether ex-
pression of BMPR1A gene mRNA level correlates with pro-
tein abundance remains to be determined.
Bone morphogenetic protein 4 (BMP4) has been impli-
cated in several aspects of embryonic development, espe-
cially in those organs in which epithelial–mesenchymal
interactions are essential for development, such as the kid-
ney [28, 29]. Additionally, it is a known regulator of UB
branching; firstly, by inhibiting ectopic budding from the
nephric (Wolffian) duct and, secondly, by promoting elon-
gation of the branching ureter [30]. Previously, BMP sig-
naling has been shown to regulate nephron number in mice,
as deletion of the Cv2 molecule, which normally has pro-
BMP function, resulted in reduced nephron endowment
[31]. Although three missense mutations in BMP4 have
been recently detected in children with renal hypodysplasia
(RHD), characterized by reduced kidney size and/or malde-
velopment of the renal tissue [14], we failed to detect an
association between rs17563 BMP4 polymorphism and
newborn kidney size. There was, however, a trend towards
lower individual and total kidney volumes in carriers of the
CC genotype. Recently, Cappaso et al. [15] reported signif-
icantly lower BMP4 mRNA levels in CC homozygotes as
compared to carriers of the T allele. Thus, the study cohort
might be too small to definitively exclude effects of this
BMP4 variant. However, if the lack of association is a true
negative result, this finding seems to be supported by Cain
and Bertram [29], who showed that despite reduced endog-
enous BMP4 mRNA levels, most BMP4 heterozygous
mouse embryos were still able to facilitate normal ureteric
Table 2 Characteristics of kidney volumes in newborns with respect to BMP4 and BMPR1A polymorphisms
Variable BMPR1A (A5659T, rs7922846) pD
a pR
a BMP4 (T455C, rs17563) pD
a pR
a
AA (n082) AT (n081) TT (n016) CC (n057) CT (n093) TT (n029)
LKV (ml) 12.8±3.4 12.8±2.9 14.4±4.8 0.951 0.062 12.7±3.0 13.0±3.6 12.9±3.4 0.560 0.951
RKV (ml) 11.7±3.0 12.3±3.0 13.6±5.4 0.247 0.070 11.8±2.7 12.1±3.4 12.8±4.0 0.429 0.247
LKV/RKV 1.1±0.3 1.1±0.2 1.1±0.2 0.484 0.947 1.1±0.2 1.1±0.3 1.1±0.3 0.858 0.484
TKV (ml) 24.4±5.8 25.1±5.1 28.0±10.0 0.505 0.043 24.5±5.3 25.1±6.4 25.7±6.6 0.449 0.505
TKV/BSA (ml/m2) 105.7±23.3 107.8±19.8 122.7±43.8 0.327 0.013 106.1±20.9 108.1±25.0 112.3±30.1 0.457 0.327
LKV left kidney volume, RKV right kidney volume, TKV total kidney volume, BSA body surface area
a pD and pR are test probabilities with dominant (TT + AT versus AA [rs7922846], TT + CT versus CC [rs17563]) and recessive (TT versus AT +
AA [rs7922846], TT versus CT + CC [rs17563]) modes of inheritance of the minor alleles, respectively
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branching morphogenesis during development. Although
many mutations within BMP4 leading to various phenotypes
are known [32], to our knowledge, rs17563 is the only
identified polymorphism in the coding region [33]. As the
rs17563 BMP4 polymorphism was previously found to be
significantly associated with BMP4 mRNA levels and
BMP4 plasma levels [15], we also tried to account for
possible ligand-dependent (BMP4) up- or down-regulation
of BMPR1A. To do this, we analyzed TKV values for
compound genotypes composed of BMP4 and BMPR1A,
but no associations were found (data not shown).
In order to minimize the effects of potential confounding
variables that could create a spurious association, the study
was conducted in a carefully selected group of newborns all
of whom met all criteria for inclusion. The sonographic
examinations of kidney size were performed according to
protocols in the literature that give reproducible results, and
kidney volumes were similar to those of a large cohort of
Danish newborns who were studied within the first 5 days of
life [20]. The BMPR1A genotype distribution in our group
was in accordance with Hardy-Weinberg equilibrium. TKV/
BSA in infants with at least one A BMPR1A allele ranged
from 54.5 to 173.2 ml/m2 versus 69.2 to 219.3 ml/m2 in TT
homozygotes, and the left/right kidney volume ratio did not
differ among newborns with the various BMPR1A geno-
types. Therefore, it is wrong to assume that the significant
association is due to a few newborns with very small
kidneys or with unilateral renal hypoplasia.
The potential weakness of the present study stems from
the fact that our sample was not systematically tested for
genetic heterogeneity. Population stratification is a concern
in both case-control and cross-sectional studies [34]. More-
over, Berger et al. showed that population substructures can
be detected even in an apparently homogenous population
[35]. The confounded association resulting from stratifica-
tion or admixture within a population can be reduced by
matching by geographical region and/or by markers of eth-
nic origin [36]. The population now inhabiting the region of
West Pomerania resulted from extensive mixing of Polish
people from all regions of Poland after the Second World
War and therefore can provide a representative sample of a
Caucasian-European population [37]. In addition, the
rs7922846 allele frequencies were similar to those reported
in adult control subjects in a Leipzig cohort, a self-contained
Sorbian population in Germany [16], and Utah residents
with ancestry from Northern and Western Europe from the
HapMap project [38]. Although, we believe, it is very un-
likely that our cohort of newborn infants is a biased sample
due to population stratification, other studies in populations
of the highest possible level of homogeneity may be needed.
In summary, our data suggest that common genetic var-
iation in BMPR1A may play a role in early human nephro-
genesis, through putative increase in BMPR1A mRNA
expression and thereby, presumably, defective ureteric bud
branching leading to subtle reduction in nephron number
and subsequently to slightly smaller kidney size in healthy
newborns. Furthermore, rs7922846 BMPR1A polymor-
phism may, in concert with other common polymorphisms
in developmental genes including PAX2 [5], RET [10],
ALDH1A2 [9], OSR1 [17] or ACE [18], partially account
for subtle variation in kidney size at birth reflecting congen-
ital nephron endowment. Thus, newborns possessing an
unfavorable polygenic profile associated with reduced neph-
ron number may benefit from heightened surveillance for
essential hypertension in adulthood.
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